Jeffrey Spaeder, MD, MBA, is the Chief Medical and Scientific Officer for IQVIA. In this role, he is the lead medical and scientific expert and is involved with the company’s oversight of scientific integrity, governance of early-phase development, quality assurance, and bioethics. As part of his focus on the patient, Dr. Spaeder serves as the Executive Sponsor of IQVIA’s Clinical Trial Diversity & Inclusion Initiative.
Dr. Spaeder has over 25 years of medical and research experience, and since 2005 has worked in the life sciences industry. Prior to joining IQVIA, Dr. Spaeder worked in roles of increasing responsibility at Abbott Laboratories and Takeda in clinical development, pharmacovigilance, and medical affairs. He also was a cardiologist on the faculty of Johns Hopkins School of Medicine, where he performed novel research on mass customization of personalized healthcare and telemedicine, and he holds several patents based on his research and insights.
Dr. Spaeder holds an MD degree from Johns Hopkins School of Medicine and completed specialty training in internal medicine at Johns Hopkins and sub-specialty training in cardiovascular medicine from Johns Hopkins and the National Heart, Lung, and Blood Institute. He holds a BS in Engineering Science from Pennsylvania State University and an MBA with a concentration in Finance from Northwestern University’s Kellogg School of Management.
Main Menu
The Learning Phase includes:
Connecting Clinical Trial Sponsors: Bringing sponsors and local EQBMED-selected sites together to work as partners.
Sharing Key Learnings: Sharing important lessons learned from these partnerships.
Building Robust Infrastructure: Creating a strong support system that continues to support the growth and aspirations of local sites.
